Biochemical control and 2-year tolerability following stereotactic body radiotherapy for localized prostate cancer: a multicenter study in Spain.
Romero Zoghbi SE, López Campos F, Ocanto A, Sanz-Rosa D, Thuissard-Vasallo IJ, Andreu Vázquez C, Laria C, Fernández Ibiza J, Andreescu Yagüe J, Krumina E, Mateos M, Dzhugashvili M, Glaría LA, Gonsalves D, Fernández C, Esteban D, de la Fuente JB, González Ferreira JA, Ristori A, Rivas D, López E, Bezares Alarcón AB, Aakki L, Larrea L, García Cuesta JÁ, Zamboglou C, Alongi F, García García R, Couñago F.
Romero Zoghbi SE, et al. Among authors: de la fuente jb.
Clin Transl Oncol. 2026 Feb 7. doi: 10.1007/s12094-026-04235-6. Online ahead of print.
Clin Transl Oncol. 2026.
PMID: 41653361